Transcatheter closure of patent ductus arteriosus using controlled-release coils

Acta Paediatrica Japonica; Overseas Edition
A CelikerM Lenk

Abstract

Controlled-release coils have become available recently for the closure of patent ductus arteriosus (PDA). Transcatheter closure of patent arterial ducts was attempted in 13 patients, ranging in age from 5 months to 15 years, mean 4.1 years. Implantation of controlled-release PDA coils was attempted via the femoral artery through 5 Fr catheters in all cases except one, in whom both the femoral arterial and venous routes were used. The procedure was successful in 10 of the 13 patients. In these, the pulmonary artery systolic pressure ranged between 25 and 42 mmHg and the duct diameter varied from 1.5 to 6 mm at its narrowest point. Six of the patients received a single coil. Two coils were inserted in three patients and three coils in one patient. In three patients the ducts were too large for safe release of the coils, despite attempted implantation of up to three coils simultaneously. These coils were easily withdrawn into the catheter. Immediately at the end of the procedure, the duct was completely occluded in nine of the 10 patients, and in one patient there was a small residual flow. The procedure time varied between 35 min and 2.5 h, mean 81 min and the fluoroscopy time varied from 5 to 78 min, mean 25 min. None of the pa...Continue Reading

References

Jul 1, 1975·The American Journal of Roentgenology, Radium Therapy, and Nuclear Medicine·C GianturcoS Wallace
Mar 15, 1992·The American Journal of Cardiology·P A CambierJ W Moore
Mar 15, 1991·The American Journal of Cardiology·K E SørensenO K Hansen
Jul 15, 1989·The American Journal of Cardiology·M A Ali KhanW Sawyer
Oct 1, 1989·The Journal of Pediatrics·L A LatsonD A Danford
Nov 15, 1988·The American Journal of Cardiology·J D DyckR D Rowe
Jun 1, 1984·The Journal of Thoracic and Cardiovascular Surgery·H R WagnerJ A Waldhausen
May 1, 1980·Radiology·V P ChuangC Gianturco
Mar 1, 1994·Journal of the American College of Cardiology·J W MooreW C Kirby

❮ Previous
Next ❯

Citations

Dec 29, 2000·Indian Journal of Pediatrics·J L Wilkinson
Feb 1, 1997·The Annals of Thoracic Surgery·O GalalZ al-Halees
Mar 21, 1998·Journal of the American College of Cardiology·R G GrabitzG von Bernuth
Nov 18, 1997·Acta Paediatrica Japonica; Overseas Edition·H TomitaS Chiba
Feb 19, 1998·The American Journal of Cardiology·S B JureidiniP S Rao
Dec 17, 1997·The American Journal of Cardiology·P S RaoS Chen
May 2, 2002·Pediatrics International : Official Journal of the Japan Pediatric Society·Noriyuki HanedaSung-Hae Kim
Aug 25, 2000·Indian Journal of Pediatrics·J L Wilkinson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.